L3VLUP
ProSign in

RVMD in the 13F filings

Revolution Medicines Inc · CUSIP 76155X100

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
16 Feb 2024
latest of these filings; the earliest 12 Feb 2024
Managers listing it
8
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 6 listed it in both
Shares listed
35,561,497
combined, among listed positions
Reported value
$1.0bn
combined, at the quarter end

Among the 93 comparable managers: 5 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing RVMD in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

8 of 8 holders

ActionFiling
Wellington Management Group LLP14,882,086$427m0.08%Added+4,309,61112 Feb 2024 (the filing on sec.gov)
Farallon Capital Management LLC6,736,854$193m0.88%Added+3,411,37414 Feb 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc4,636,353$133munder 0.1%Trimmed-458,35316 Feb 2024 (the filing on sec.gov)
Woodline Partners LP2,960,040$85m0.92%Trimmed-185,40514 Feb 2024 (the filing on sec.gov)
Holocene Advisors LP2,882,155$83m0.32%Added+691,43314 Feb 2024 (the filing on sec.gov)
Janus Henderson Group Ltd2,199,480$63munder 0.1%Trimmed-41,25914 Feb 2024 (the filing on sec.gov)
Marshall Wace LLP1,208,929$35m0.06%Addedn.a.14 Feb 2024 (the filing on sec.gov)
Moore Capital Management LP55,600$1.6munder 0.1%Newnew14 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
10 in Q3 2024 to 17 in Q2 2026

Tracked managers listing it, at least.

051015202020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RVMD by quarter
QuarterHoldersReported valueBuyersSellers
Q1 20204$21mn.a.n.a.
Q2 20201$29mn.a.n.a.
Q3 20203$388mn.a.n.a.
Q4 20204$451mn.a.n.a.
Q1 20215$846mn.a.n.a.
Q2 20215$325mn.a.n.a.
Q3 20213$133mn.a.n.a.
Q4 20213$174mn.a.n.a.
Q1 20223$174mn.a.n.a.
Q2 20223$189mn.a.n.a.
Q3 20223$206mn.a.n.a.
Q4 20223$263mn.a.n.a.
Q1 20235$526mn.a.n.a.
Q2 20237$685mn.a.n.a.
Q3 20238$766mn.a.n.a.
Q4 20238$1.0bn53
Q1 202410$1.3bn72
Q2 20249$1.6bn44
Q3 202410$1.9bn63
Q4 202411$2.2bn82
Q1 20257$1.7bn51
Q2 20258$1.7bn34
Q3 20257$2.2bn33
Q4 202518$4.3bn239
Q1 202615$4.8bn1420
Q2 202617$10.3bn1623

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RVMD and GILD →RVMD and AMGN →RVMD and ARGX →Choose a stock to compare with RVMD →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RVMD, latest filings →Back to the 13F Explorer →